RemeGen   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Yantai China (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2015
NCT02882087
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

RemeGen | RemeGen Co., Ltd.